利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Objectives: understand how Abo-BoNT-A must be diluted in Poli-Bio-Revitalizers + HA (PBRHA) to get best results and avoid complications(1)

Introduction: aging of the skin and dermis is crucial in the appearance of our patients and it is one of the most important signe of age increase. PBRHA are very effective if injected in the right very superficial layers of the epidermis, especially at the basal membrane. At this level there are many targets very sensitive also to BoNT-A and so the synergistic effect of PBRHA + BoNT-A make sence to revitalize superficial payers of the skin. The author published many years ago in his book Facial Aging, 1st edition, the personal experience.

Materials / method: the author hase diluted a PBR+HA 3 ml with AboBoNT-A 125U according to a particular technique described in the presentation. in the upper-mid third of the face only PBR + HA is injected intradermally using a needle 0,6 mm long while in the lower third, neck and decolletè, Abo-BoNT-A is added to the remaining solution and injected with a particular device, a 0,6 mm needle, to arrive exactly to the target, the basal membran and avoid diffusion deeper and so complications.

Results: results and complications are shown in the presentation and some clinical cases are discussed

Conclusion: PBRHA with mesoAboBoNT-A is a very effective and easy technique if done following some rules the Author has published many years ago in his book on Facial Aging. Add more units, dilute differently or treat different areas can lead to complications and less results, missing the right target and the perfect depthness.

Bibliography:
1) Redaelli A.: Poly-HA-Biorevitalization (PHaB) and MesobotulinumtoxinA: Indications and Personal Technique. ijclinmedcasereports.com, 34- 4, DOI: 10.46998/IJCMCR.2023.34.000841

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
是
请注明名称（个人，公司，学会等等）: fillmed and galderma are the companies that distribute the products used in this presentation. I did not receive any funding by the involved companies but only my experience is described.

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
是
请注明名称（个人，公司，学会等等）: Benev - Consultant, Luvo Consultant,

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Objectives: To present an evidence-based, dermatologist’s approach to panfacial rejuvenation of the male face using lasers, EBD and injectables

Introduction: Men have become a significant segment of the aesthetic industry. Despite the demand, men have been ignored in studies involving beauty and ageing, which focused mainly on the female face. Successful aesthetic treatments by dermatologists require a holistic approach on skin biology and proper recognition of skin diseases and features of ageing. Gender differences in anatomy, behaviour and rejuvenation goals should also be considered. Balance and harmony are essential to achieve a favorable cosmetic outcome.

Materials / method: 9 males aged 25 to 71 (mean age=38), Jan 2019-present. All patients were initially seen because of skin diseases. The patients were classified in the following age groups: 25-34.11; 35-44.11; 45-54.11; 55-64.11; 65-75.
All patients underwent non-invasive and minimally invasive aesthetic procedures depending on the initial and follow-up treatment plan and included the following:
1. Appropriate skin care
2. Chemical peels
3. Resurfacing, pigment and vascular lasers
4. Energy-based devices
5. Neurotoxins
6. Dermal fillers
7. Mesolipolysis
8. Biostimulators and exosomes
9. Thread lift

Results: Six out of 9 patients belong to the 25-34.11 age group and initially presented with skin diseases. Request for aesthetic procedures started only when their skin condition has improved dramatically. Three patients who belong to the older age group requested for regular rejuvenation treatments to slow down the signs of ageing. All patients expressed satisfaction on combination treatments using lasers, EBD, and injectables. No serious side effects were encountered on subsequent follow-up. Baseline and follow-up photos will be presented.

Conclusion: The number of male patients seeking aesthetic treatment continuosly increase. The dermatologist should be able to create a more holistic plan which do not only address enhancement of facial features, but also consider overall skin health, health lifestyle/behavior and rejuvenation goals. The scientific community should also broaden our understanding of the male face and appropriate treatment with minimally invasive cosmetic procedures.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作的完成感谢以下机构的支持： Fillmed Laboratories

利益冲突声明

您有否接受任何资金来支持研究这个主题？
是
请注明名称（个人，公司，学会等等）: symatese

您是否接受过关于这项研究的任何酬金或其他报酬？
是
请注明名称（个人，公司，学会等等）: symatese

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
是
请注明名称（个人，公司，学会等等）: symatese

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
是
请注明日期: pending
和审阅情况: 2020

这项工作的完成感谢以下机构的支持： symatese

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
是
请注明名称（个人，公司，学会等等）: I am a KOL for MERZ AESTHETICS

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。